GLENMARK LIFE SCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 855.2 INR | +2.28% |
|
+2.94% | +30.15% |
| 15/05 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
| 25/04 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GLENMARK LIFE SCIENCES LIMITED | Other Pharmaceuticals | +2.28% | +2.94% | +30.15% | +59.24% | - | 1.23B | - | - | - |
